The CELT ACD System is a next generation vascular closure device providing safe, effective and reliable closure of femoral arterial access sites following catheterization procedures with 5F to 7F sheaths.1 2 3
Designed for procedural efficiency, the CELT ACD device provides rapid and complete hemostasis in anticoagulated patients without limitations in calcified vessels.1 2 3
The one-piece implant actively seals the puncture to minimize risk of late bleeding.3
This safe and effective approach to small bore arterial closure enables early ambulation and discharge, per physician discretion, to simplify workflow, transform the patient experience, and reduce overall cost of care. 3 4 5 6
1Wong et al. Catheterisation and Cardiovascular Interventions; 90:756-765 (2017)
2Cahill et al. Heart; 100: A44 (2014)
3ICELT IFU (Rev 3)
4Hussain. Presentation at Charing Cross, UK. April 2019
5Economic model, Company data on file.
6Jost et al. Letter to the editor. 09.02.20. Journal of Vascular Access.
Elective closure of a femoral arterial puncture inter-operatively to facilitate immediate ambulation for patient to have a bowel movement, then return to the procedure room for re-access, case completion and re-closure through the same common femoral artery.
Objectives: This study compared the performance of Celt ACDVR, a novel stainless steel based vascular closure device versus manual compression for femoral arteriotomy site hemostasis in patients undergoing percutaneous coronary procedures.
Conclusions: After 6-F percutaneous invasive procedures in fully anticoagulated patients, TTH was signifi-cantly reduced in patients assigned to Celt ACDVR compared to patients managed with MC. The 30-day rates of vascular complications were similarly low in both groups. (CELT ACD Trial; NCT01600482)
Vasorum (Dublin, Ireland) and Veryan Medical (Horsham, UK) have announced that from today Veryan Medical will support Vasorum in the commercialization of the Celt ACD in the USA. The Celt ACD, is an Arterial Closure Device that has been used in more than 60,000 patients to date with excellent clinical results following percutaneous catheter-based vascular procedures.…